Health Institute Carlos III
If you are the contact person for this centre and you wish to make any changes, please contact us.
Director of the National Centre for Tropical Medicine (CNMT) at the Carlos III Health Institute
PhD in Pharmacy, Professor of Human Physiology at the University of Navarra, member of the CIBER Physiopathology of Obesity, Carlos III Health Institute and IDISNA (Navarra)
Head of the Influenza and other Respiratory Virus Surveillance Group of the National Epidemiology Centre.
Researcher at the Reference and Research Laboratory in Mycology, National Microbiology Centre, Instituto de Salud Carlos III
Senior Scientist at the Health Institute Carlos III
HIV, STI and hepatitis B and C Surveillance Unit. National Centre of Epidemiology, Health Institute Carlos III
Researcher in social epidemiology, public health and biostatistics
Researcher with a PhD employed at the National Epidemiology Centre of the Carlos III Health Institute (ISCIII)
Research scientist and member of the Department of Climate Change, Health and the Urban Environment at the Carlos III Health Institute
Senior Scientist at the Special Pathogens Research and Reference Laboratory of the National Microbiology Centre of the Carlos III Health Institute
Director and Research Scientist at the Institute for Rare Diseases Research (IIER), Carlos III Health Institute (ISCIII)
Researcher at the National Center for Microbiology - Carlos III Health Institute
Senior scientist at the Reference Laboratory for Influenza and Respiratory Viruses of the National Microbiology Centre.
Scientific researcher at the National Epidemiology Centre - Carlos III Institute of Health
Head of the Respiratory Virus and Influenza Research Group of the Carlos III Health Institute
Full professor of Pathological Anatomy at the University of Oviedo, Scientific Director of the Principality of Asturias Biobank (BioPA) and Coordinator of the Organoid hub of the ISCIII Biomodels and Biobanks platform
Senior Scientist, Immunology Laboratory, Carlos III Health Institute
Research Professor at IDIBAPS-Hospital Clínic de Barcelona and Scientific Director of CIBEREHD - Carlos III Health Institute
Researcher in Vaccine-Preventable Disease Epidemiology at the National Centre of Epidemiology of the Health Institute Carlos III and member of CIBERESP
Scientific researcher at the Reference and Research Laboratory for Immunopreventable Viral Diseases of the National Microbiology Centre - Carlos III Health Institute
Research professor and member of the Departament on Climate Change, Health and the Urban Environment at the Carlos III Health Institute
Senior Researcher, Head of the Enterovirus and Viral Gastroenteritis Unit (Reference and Research Laboratory for Immunopreventable Viral Diseases), Centro Nacional de Microbiología, Instituto de Salud Carlos III
Head of the Central Scientific-Technical Units and Head of the Veterinary Unit of the Carlos III Health Institute
Head of the National Reference Laboratory for Gastroenteritis-Producing Viruses of the National Microbiology Centre - Carlos III Health Institute
Postdoctoral researcher at the Instituto de Investigaciones Raras Health Institute Carlos III
Virologist at the Reference Laboratory for Influenza and Respiratory Viruses of the National Microbiology Centre - Carlos III Health Institute
Cancer epidemiologist and Director General of the Carlos III Health Institute
Researcher at the National Epidemiology Centre of the Carlos III Health Institute, Associate Professor of Preventive Medicine and Public Health at the University of Alcalá.
Researcher at the National Epidemiology Centre (CNE-ISCIII)
Scientific researcher at the Cancer and Environmental Epidemiology Unit of the National Epidemiology Centre, Carlos III Health Institute, member of CIBERESP and co-coordinator of the Cancer Epidemiological Surveillance Sub-programme - VICA of CIBERESP
Senior Researcher at the Carlos III Health Institute, Head of the Neuro-oncology Unit at the Chronic Diseases Research Unit (UFIEC-ISCIII)
ICREA Research Professor, Director of Andero Lab and the Rodent Behavioral Core at the Autonomous University of Barcelona (UAB), and researcher in the Department of Psychobiology and Methodology of Health Sciences at the UAB and at the Carlos III Health Institute, CIBERSAM
Assistant Professor in the Department of Preventive Medicine and Public Health at the University of Valencia, and researcher at the CIBER Centre for the Physiopathology of Obesity and Nutrition (CIBEROBN) at the Carlos III Institute
Researcher at the Reference Laboratory for Influenza and Respiratory Viruses at the Centro Nacional de Microbiología - Instituto de Salud Carlos III
Medical Epidemiologist at the National Epidemiology Centre - Carlos III Health Institute
Researcher in the Viral Biology laboratory of the Carlos III Health Institute
Senior Scientist at the Carlos III Health Institute, in the area of Environmental Toxicology of the National Center for Environmental Health
HIV, STI and hepatitis B and C Surveillance Unit. National Centre of Epidemiology, Health Institute Carlos III
An international team, including several Spanish groups and coordinated by the Institute for Bioengineering of Catalonia (IBEC), has developed a pioneering technology that allows for the creation of multiple human kidney organoids, their combination with pig kidneys outside the body, and their successful transplantation back into the same animal. The method could contribute to improving future research and, according to the authors, allows us to envision a future clinical scenario in which organs destined for transplantation can be treated and conditioned before implantation. The work is published in Nature Biomedical Engineering.
A team has analysed estimated data on exposure to pollution during and after pregnancy and its possible link to a diagnosis of autism in more than two million births in Canada between 2002 and 2022. Their findings are that greater exposure to small PM2.5 particles containing sulphate or ammonium is associated with a higher likelihood of receiving a diagnosis of autism in the first five years of life. A slightly increased proportion was also observed with greater exposure to ozone during certain weeks of pregnancy and in the first year of life. The results are published in the journal JAMA Network Open.
A team from China has reported the results of the first liver transplant from a pig to a living human. Earlier this year, a procedure that served as a proof of concept was published, but it was performed on a brain-dead person. In this case, after modifying 10 genes in the porcine liver, an auxiliary transplant—not removing the entire organ—was performed on a 71-year-old patient with cirrhosis and liver cancer. It worked well for the first month, but on day 38, the graft had to be removed due to the development of complications, and the patient died on day 171. According to the researchers, who published the case in the Journal of Hepatology, this is "a fundamental step that demonstrates both the promise and the obstacles that remain to be overcome".
The Karolinska Institute has awarded the Nobel Prize in Medicine or Physiology to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi for describing how the immune system is regulated so as not to harm us. His groundbreaking discoveries on peripheral immune tolerance have spurred the development of new treatments for cancer and autoimmune diseases.
A new school year has begun, and pollution, which exceeds recommended limits in many urban centres, will once again affect children and their families. What consequences could this have on health? How does climate change affect it? What solutions can be implemented? SMC Spain organised an informative session with Julio Díaz and Cristina Linares to answer these questions.
Avian influenza has returned to Spain this summer. In addition to a few cases in wild birds, since 18 July there have been several outbreaks in poultry in different autonomous communities, causing the country to lose its disease-free status. To answer questions about the situation, its possible causes, evolution and consequences, SMC Spain organised an information session with researchers Inmaculada Casas, Ursula Höfle and Elisa Pérez Ramírez.
More than 350 million people in North America and Europe may have been affected by fine particulate matter (PM2.5) pollution from the 2023 Canadian wildfires, according to estimates from a study published in Nature. The authors estimate that 5,400 acute deaths in North America and 64,300 chronic deaths in North America and Europe were attributable to exposure to these particles originating from Canadian forest fires.
The Planetary Health Diet promotes environmentally sustainable consumption, based, among other things, on increasing vegetable intake and reducing dairy and red meat consumption. Previous studies had found an association with better human health, although there were some conflicting results. Now, a study combining two cohorts of more than 150,000 people and a meta-analysis of 37 studies involving more than three million volunteers reinforces this association, finding that greater adherence to the diet is associated with lower all-cause mortality. The results are published in the journal Science Advances.
A team in China has transplanted a pig lung, genetically modified using CRISPR, into a brain-dead human. According to the researchers, this is the first time a lung transplant of this kind has been performed. The organ remained viable for the nine days of the study, although it showed some signs of damage and immune rejection. The results are published in the journal Nature Medicine.
The Pan American Health Organisation has maintained its epidemiological alert for Oropouche fever since it was first issued in February 2024. Although the virus only circulates endemically in the Americas, the importation of cases to Europe following international travel is keeping health agencies and authorities on alert.